Searched for
MERCK KGAA
Merck Ltd renamed as Procter & Gamble Health LtdThe consumer health business was transferred to P&G on December 1, 2018, it added.- P&G proposal for stake acquisition in company gets govt nod: Merck LtdGovt has approved the proposal of P&G Overseas India BV for acquisition of up to 77.80 per cent of the paid-up equity share capital of the ...
- CCI approves P&G's stake acquisition in MerckThe global deal is for about 3.4 billion euro in cash.
- Merck advances 4% as arm may sell consumer health businessShares of the company opened at Rs 1,205 and touched a high and low of Rs 1,280 and Rs 1,205, respectively, in trade.
- Merck KGaA may sell consumer health businessMerck KGaA’s global consumer health business achieved net sales of €860 million (around Rs 6,555 crore) in 2016, according to the company’s...
- Merck sees market for novel therapies, to focus on its oncology pipelineMerck is betting big on its oncology pipeline, in the field of immunotherapy that has come to define new-age cancer treatment.
- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...
- German Pharma firm Merck to shut down Bangalore GeNeiMerck KGaA has decided to close down Bangalore GeNei, a company it had acquired in 2009 to bolster capabilities in design and production of...
- German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health businessMerck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion s...
- EC fines Ranbaxy, others for blocking cheaper drugsEC imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper gener...
- EU regulators to fine Ranbaxy, Merck, others: SourcesThe European Union’s Anti-Trust Commission may impose a fine on Ranbaxy Labs among other generic and innovator firms, including Denmark-bas...
- Small towns to drive Merck India's growthThe Indian arm of German drug maker Merck KgaA is looking at small towns to drive its growth, tells Merck Ltd (India) managing director Mar...
- Merck KGaA eyes 20 pc growth from India in next 3 yearsGerman drug firm Merck KGaA today said its expects sales revenue to grow by 20 per cent in the next three years in India.
- Merck KGaA plans to push SevenSeas Original in Indian marketIt's probably a brand most of us remember from childhood - SevenSeas Original cod liver oil and in some cases abhorred because of the stron...
- Merck KGaA acquires Bangalore-based bioscience companyMerck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specia...
- Ranbaxy puts in bid for Merck's generic unitIndia's biggest drug maker Ranbaxy Laboratories Ltd has put in its bid to acquire generic business of German pharmaceutical firm Merck.
- Ranbaxy sees synergy dose in Merck unitRanbaxy’s reported interest in the Merck KGaA’s generic division has the potential of being one of the most synergistic acquisitions in rec...
- Milestone for GlenmarkGlenmark’s out-licensing deal with the German pharma major, Merck KGaA, for its diabetes molecule, a DPP-IV inhibitor, is an important mile...
- Merck inks pact to develop, sell Glenmark diabetes drugGerman pharma major Merck KGaA and Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharma India, announced...
- Glenmark, Merck sign pact for 8 generic productsGlenmark Pharmaceuticals Ltd on Monday said it has signed a pact with Germany-based Merck Generic Group for the joint development, filing a...
Load More
